Pharmacopoeia

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 03.12.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Collection of regulations for the manufacture of medicinal products, divided into different pharmacopoeias in accordance with §55 of the German Medicinal Products Act (AMG), see classification. The pharmacopoeias contain information on quality, testing, storage, dispensing and designation, as well as recognized pharmaceutical rules.

ClassificationThis section has been translated automatically.

  • German Pharmacopoeia ( DAB)
  • German Drug Codex ( DAC); see also NRF
  • Pharmacopoea Europaea (Ph. Eur.)
  • Pharmacopoeia of the German Democratic Republic (AB-DDR)
  • Pharmacopoeia for Austria (ÖAB)
  • Pharmacopoea Helvetica (Ph. Helv.)
  • Homeopathic Pharmacopoeia (HAB)
  • British Pharmaceutical Codex (BPC)
  • American Pharmacopoeia (USP)
  • European Pharmacopoeia (Ph. Eur.)

LiteratureThis section has been translated automatically.

  1. https://www.bfarm.de/DE/Arzneimittel/Zulassung/Zulassungsrelevante-Themen/Arzneibuch/_node.html
  2. Blaschek W (2015) Wichtl tea drugs and phytopharmaceuticals. A handbook for practice. Wissenschaftliche Verlagsgesellschaft Munich. S 37

Authors

Last updated on: 03.12.2024